SYRE ▼ -5.8% - Spyre Therapeutics, Inc.
$SYRE reported Q3 2026 EPS of -$0.94, missing the -$0.83 estimate by 13.3%. Revenue was $0. No analyst estimate was published for revenue.
03-NOV-2026 04:21 PM ET
Share this post
More filings for $SYRE
SYRE ▲ +4.4% - Spyre Therapeutics, Inc.Nov 3, 2026SYRE ▼ -1.4% - Spyre Therapeutics, Inc.Oct 18, 2026SYRE - Spyre Therapeutics, Inc. - SEC Filing Update (09-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 9, 2026SYRE ▼ -4.6% - Spyre Therapeutics, Inc.Oct 6, 2026SYRE ▼ -3.7% - Spyre Therapeutics, Inc.Oct 5, 2026SYRE ▲ +3.4% - Spyre Therapeutics, Inc.Oct 2, 2026
View full $SYRE filing history →💬 Comments
Loading comments…
Leave a comment